NASDAQ: UNCY
Unicycive Therapeutics Inc Stock Ownership - Who owns Unicycive Therapeutics?

Insider buying vs selling

Have Unicycive Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when UNCY insiders and whales buy or sell their stock.

UNCY Shareholders

What type of owners hold Unicycive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gaurav Aggarwal9.43%11,370,152$7.74MInsider
Vivo Capital LLC9.43%11,370,152$7.74MInstitution
Great Point Partners LLC9.10%10,980,000$7.48MInstitution
Octagon Capital Advisors LP8.29%10,000,000$6.81MInstitution
Nantahala Capital Management LLC7.79%9,391,994$6.40MInstitution
Logos Global Management LP4.21%5,078,927$3.46MInstitution
Walleye Capital LLC3.39%4,094,256$2.79MInstitution
Shalabh K. Gupta2.10%2,527,449$1.72MInsider
Silverarc Capital Management LLC2.00%2,413,489$1.64MInstitution
Acuta Capital Partners LLC1.95%2,352,887$1.60MInstitution

1 of 3

UNCY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UNCY49.68%11.74%
SRZN22.27%77.73%Net BuyingNet Buying
XBIT14.69%45.12%
JSPR20.68%79.32%Net Buying
PDSB18.00%25.86%Net Buying

Unicycive Therapeutics Stock Ownership FAQ

Who owns Unicycive Therapeutics?

Unicycive Therapeutics (NASDAQ: UNCY) is owned by 49.68% institutional shareholders, 11.74% Unicycive Therapeutics insiders, and 38.59% retail investors. Gaurav Aggarwal is the largest individual Unicycive Therapeutics shareholder, owning 11.37M shares representing 9.43% of the company. Gaurav Aggarwal's Unicycive Therapeutics shares are currently valued at $7.74M.

If you're new to stock investing, here's how to buy Unicycive Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.